Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Pulmonary Hypertension, April 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 152 articles:
HTML format


 

Single Articles

  1. SHEN M, Zheng C, Chen L, Li M, et al
    LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4.
    Biomed Pharmacother. 2023;162:114569.
    PubMed    
    Abstract available

  2. AKASLAN D, Aslanger E, Atas H, Kocakaya D, et al
    Are Guideline-recommended Risk Classification Schemes in Pulmonary Hypertension Adequately Robust to Guide the Real-world Setting?
    Balkan Med J. 2023 Mar 31. doi: 10.4274/balkanmedj.galenos.2023.2023.
    PubMed    
    Abstract available

  3. LUHADIA K, Yashi K, Virk J, Parikh T, et al
    Type 1 Pulmonary Hypertension and Silicosis in a Bluestone Cutter: A Case Report on Raising Awareness.
    Cureus. 2023;15:e35425.
    PubMed    
    Abstract available

  4. HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
    [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
    G Ital Cardiol (Rome). 2023;24:1e-116e.
    PubMed    


  5. YUCHI Y, Suzuki R, Yasumura Y, Saito T, et al
    Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    J Vet Intern Med. 2023 Mar 30. doi: 10.1111/jvim.16686.
    PubMed    
    Abstract available

  6. JIN N, Yu M, Du X, Wu Z, et al
    Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics.
    BMC Cardiovasc Disord. 2023;23:167.
    PubMed    
    Abstract available

  7. TAO XC, Wang JZ, Gu SC, Liu M, et al
    [Rescue balloon pulmonary angioplasty for a patient with acute exacerbation of chronic thromboembolic pulmonary hypertension supported by extracorporeal membrane oxygenation: a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:408-412.
    PubMed    
    Abstract available

  8. ALALAIWE A, Alsenaidy MA, Almalki ZS, Fayed MH, et al
    Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology.
    Pharmaceutics. 2023;15:923.
    PubMed    
    Abstract available

  9. GONZALES J, Fraidenburg DR
    Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease.
    Pharmaceuticals (Basel). 2023;16:418.
    PubMed    
    Abstract available

  10. CERNE JW, Shehata C, Ragin A, Pathrose A, et al
    Potential Prognostic Value of Native T1 in Pulmonary Hypertension Patients.
    Life (Basel). 2023;13:775.
    PubMed    
    Abstract available

  11. SHAH AJ, Beckmann T, Vorla M, Kalra DK, et al
    New Drugs and Therapies in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;24:5850.
    PubMed    
    Abstract available

  12. PARPERIS K, Velidakis N, Khattab E, Gkougkoudi E, et al
    Systemic Lupus Erythematosus and Pulmonary Hypertension.
    Int J Mol Sci. 2023;24:5085.
    PubMed    
    Abstract available

  13. BZDEGA K, Kutkowska-Kazmierczak A, Deutsch GH, Plaskota I, et al
    Prenatal Detection of a FOXF1 Deletion in a Fetus with ACDMPV and Hydronephrosis.
    Genes (Basel). 2023;14:563.
    PubMed    
    Abstract available

  14. SAKARIN S, Rungsipipat A, Surachetpong SD
    Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.
    Vet Res Commun. 2023 Mar 28. doi: 10.1007/s11259-023-10106.
    PubMed    
    Abstract available

  15. ZENG Z, Wang X, Cui L, Wang H, et al
    Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities.
    Curr Issues Mol Biol. 2023;45:2351-2371.
    PubMed    
    Abstract available

  16. MANFRINI V, Badagliacca R, Messaggio E, Poscia R, et al
    Exploratory study on the endogenous ouabain in idiopathic pulmonary arterial hypertension patients.
    Ann Ist Super Sanita. 2023;59:76-79.
    PubMed    
    Abstract available

  17. WANG K, Verma A, Fish KE, Hu JR, et al
    A Case of Fulminant Right Heart Failure Owing to Tumoral Pulmonary Hypertension.
    JACC Case Rep. 2023;10:101715.
    PubMed    
    Abstract available

  18. WANG Y, Ning WW, Jin YF, Zhu QQ, et al
    Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report.
    Thromb J. 2023;21:33.
    PubMed    
    Abstract available

  19. FAIRCLOTH JM, Bhatt ND, Chartan CA, Coleman RD, et al
    Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration.
    Front Pediatr. 2023;11:1050508.
    PubMed    
    Abstract available

  20. HICKEY T, Jayakumar S, Perrino AC Jr
    Severe Pulmonary Hypertension Meets Intraperitoneal Surgery: No Place to Inflate?
    Cureus. 2023;15:e35318.
    PubMed    
    Abstract available

  21. EINECKE D
    [Not Available].
    MMW Fortschr Med. 2023;165:19.
    PubMed    


  22. POPE JE, Denton CP, Johnson SR, Fernandez-Codina A, et al
    State-of-the-art evidence in the treatment of systemic sclerosis.
    Nat Rev Rheumatol. 2023;19:212-226.
    PubMed    
    Abstract available

  23. LIU W, Hua Y, Zheng D, Lv W, et al
    Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Circ J. 2023;87:527-535.
    PubMed    
    Abstract available

  24. PAVLOVA OS, Gulyaev MV, Gervits LL, Hurshkainen AA, et al
    capital TE, Cyrillic(1) mapping of rat lungs in (19) F MRI using octafluorocyclobutane.
    Magn Reson Med. 2023;89:2318-2331.
    PubMed    
    Abstract available

  25. ZHANG H, Zhang D, Wang X, Liu Y, et al
    Prognostic implication of a novel right ventricular injury score in septic patients.
    ESC Heart Fail. 2023;10:1205-1213.
    PubMed    
    Abstract available

  26. HU Y, Zong Y, Jin L, Zou J, et al
    Reduced Apela/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
    Heart Lung. 2023;59:8-15.
    PubMed    
    Abstract available

  27. GALDINO GAM, Rehder-Santos P, Linares SN, Beltrame T, et al
    Cerebral oxygenation during cardiopulmonary exercise testing in cardiorespiratory diseases: A systematic review.
    Heart Lung. 2023;59:23-32.
    PubMed    
    Abstract available

  28. JONAS K, Zulawinska B, Borys A, Wolkow P, et al
    A new mutation in the EIF2AK4 gene in familial pulmonary veno-occlusive disease.
    Pol Arch Intern Med. 2023;133:16413.
    PubMed    


  29. DANDOY CE, Tsong WH, Sarikonda K, McGarvey N, et al
    Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
    Transplant Cell Ther. 2023;29:282.
    PubMed    
    Abstract available

  30. SAITO Y, Omae Y, Mizobuchi S, Fujito H, et al
    Prognostic significance of pulmonary arterial wedge pressure estimated by deep learning in acute heart failure.
    ESC Heart Fail. 2023;10:1103-1113.
    PubMed    
    Abstract available

  31. NAESSEN T, Einarsson G, Henrohn D, Wikstrom G, et al
    Peripheral Vascular Ageing in Pulmonary Arterial Hypertension as Assessed by Common Carotid Artery Intima Thickness and Intima/Media Thickness Ratio: An Investigation Using Non-Invasive High-Resolution Ultrasound.
    Heart Lung Circ. 2023;32:338-347.
    PubMed    
    Abstract available

  32. TAKAYASU H
    Upregulated TSP1 and CD47 expression in the lung in nitrofen-induced congenital diaphragmatic hernia.
    Pediatr Int. 2023;65:e15447.
    PubMed    
    Abstract available

  33. SAID SM, Hoggard E, Narasimhan S
    Surgical Experience With Crossed and Anomalous Origin of the Pulmonary Arteries From the Pulmonary Trunk: A Single Center Report of 24 Cases.
    World J Pediatr Congenit Heart Surg. 2023;14:185-193.
    PubMed    
    Abstract available

  34. RAKO ZA, Kremer N, Yogeswaran A, Richter MJ, et al
    Adaptive versus maladaptive right ventricular remodelling.
    ESC Heart Fail. 2023;10:762-775.
    PubMed    
    Abstract available

  35. PICCARI L, Allwood B, Antoniou K, Chung JH, et al
    Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hype
    Pulm Circ. 2023;13:e12213.
    PubMed    
    Abstract available

  36. CREA F
    Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension.
    Eur Heart J. 2023;44:1193-1196.
    PubMed    


  37. KHURANA J, Orbach DB, Gauvreau K, Collins SA, et al
    Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes.
    J Pediatr. 2023 Apr 4:113404. doi: 10.1016/j.jpeds.2023.113404.
    PubMed    
    Abstract available

  38. GONG C, Guo X, Wan K, Chen C, et al
    Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
    J Magn Reson Imaging. 2023;57:1518-1528.
    PubMed    
    Abstract available

  39. ILONZE OJ
    Outcomes of pregnancy with pulmonary hypertension: low risk or a false dawn?
    Cardiovasc J Afr. 2023;34:1.
    PubMed    


  40. CHANG HP, Lien R, Chu SM, Lin JJ, et al
    Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center.
    Front Pediatr. 2023;11:1055439.
    PubMed    
    Abstract available

  41. GUO W, Zhang M, Li H, Wang Y, et al
    A comparative study on the diagnostic efficacy of different diagnostic criteria for exercise pulmonary hypertension.
    Int J Cardiol. 2023 Apr 3:S0167-5273(23)00479.
    PubMed    
    Abstract available

  42. KUMAR R, Lee MH, Kassa B, Fonseca Balladares DC, et al
    Repetitive Schistosoma Exposure Causes Perivascular Lung Fibrosis and Persistent Pulmonary Hypertension.
    Clin Sci (Lond). 2023 Apr 4:CS20220642. doi: 10.1042/CS20220642.
    PubMed    
    Abstract available

  43. ELESAWY SA, El-Serogy HA, Sorour EA, Zoair AM, et al
    Plasma mid-regional proadrenomedullin level in children with pulmonary hypertension associated with CHD.
    Cardiol Young. 2023 Apr 4:1-7. doi: 10.1017/S1047951123000471.
    PubMed    
    Abstract available

  44. ZHANQIANG L, Huoqiang H, Dianxiang L
    Epigenetics mechanism and therapeutic potential of approved epi-drugs in pulmonary hypertension disease.
    Curr Top Med Chem. 2023 Apr 3. doi: 10.2174/1568026623666230403090650.
    PubMed    
    Abstract available

  45. AZAR J, Ayyad M, Jaber Y, Ayasa LA, et al
    Scurvy-induced pulmonary arterial hypertension.
    BMJ Case Rep. 2023;16:e254730.
    PubMed    
    Abstract available

  46. YANG L, Wan N, Gong F, Wang X, et al
    Transcription factors and potential therapeutic targets for pulmonary hypertension.
    Front Cell Dev Biol. 2023;11:1132060.
    PubMed    
    Abstract available

  47. SERMET R, Piliero N, Guillien A, Madoun S, et al
    Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2023;9:00590-2022.
    PubMed    
    Abstract available

  48. GAYEN S, Mamary AJ
    Predictors of hospitalization for respiratory failure among patients with sarcoidosis-associated pulmonary hypertension.
    Pulm Circ. 2023;13:e12212.
    PubMed    
    Abstract available

  49. OBIKANE H, Shimodai-Yamada S, Koizumi N, Ogino H, et al
    Histopathological Evaluation of Pulmonary Thromboendarterectomy Specimens of Chronic Thromboembolic Pulmonary Hypertension.
    J Atheroscler Thromb. 2023 Apr 1. doi: 10.5551/jat.63973.
    PubMed    
    Abstract available

  50. KUBOTA K, Imai Y, Okuyama T, Ishiyama Y, et al
    Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
    Int Heart J. 2023;64:316-320.
    PubMed    
    Abstract available

  51. WARNER ED, Brailovsky Y, Oliveros E, Bhardwaj A, et al
    High Output Heart Failure, Pulmonary Hypertension and Right Ventricular Failure in Patients with Arteriovenous Fistulas: A call to action.
    J Card Fail. 2023 Mar 31:S1071-9164(23)00108.
    PubMed    


  52. SINGH P, Deshpande S, Nagpal R, Garegrat R, et al
    Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India.
    BMC Pediatr. 2023;23:149.
    PubMed    
    Abstract available

  53. WU XH, He YY, Chen ZR, He ZY, et al
    Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype.
    Nat Commun. 2023;14:1820.
    PubMed    
    Abstract available

  54. DENIZ MF, Sinan MYA, Y Ld Z A, K N EBZR, et al
    Percutaneous Treatment of Left Main Coronary Artery Compression in a Pulmonary Artery Hypertension Patient Associated with Atrial Septal Defect.
    Turk Kardiyol Dern Ars. 2023;51:221-225.
    PubMed    
    Abstract available

  55. NATHANSEN AB, Moller AM
    [Not Available].
    Ugeskr Laeger. 2023;185:V06220421.
    PubMed    
    Abstract available

  56. YANG H, Pan J, Wang W, Guo T, et al
    Application of Artificial Intelligence-Based Auxiliary Diagnosis in Congenital Heart Disease Screening.
    Anatol J Cardiol. 2023;27:205-216.
    PubMed    
    Abstract available

  57. GRYNBLAT J, Malekzadeh-Milani SG, Meot M, Perros F, et al
    Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e029085.
    PubMed    
    Abstract available

  58. HAFEEZ N, Kirillova A, Yue Y, Rao RJ, et al
    Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e027894.
    PubMed    
    Abstract available

  59. YANG HT, Wang G, Zhu PC, Xiao ZY, et al
    Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Exp Cell Res. 2023;426:113555.
    PubMed    
    Abstract available

  60. KIZHAKKE PULIYAKOTE AS, Prisk GK, Elliott AR, Kim NH, et al
    The spatial-temporal dynamics of pulmonary blood flow are altered in pulmonary arterial hypertension.
    J Appl Physiol (1985). 2023;134:969-979.
    PubMed    
    Abstract available

  61. VAIDY A, Vaidya A
    Pulmonary arterial hypertension in pregnancy.
    Curr Opin Cardiol. 2023;38:250-256.
    PubMed    
    Abstract available

  62. TANRIVERDI LH
    Novel aspects of the renin-angiotensin system for pulmonary arterial hypertension.
    Hypertens Res. 2023;46:1049-1050.
    PubMed    


  63. REZA AA, Kohram F, Reza HA, Kalin TR, et al
    FOXF1 Regulates Alveolar Epithelial Morphogenesis through Transcriptional Activation of Mesenchymal WNT5A.
    Am J Respir Cell Mol Biol. 2023;68:430-443.
    PubMed    
    Abstract available

  64. HONG J, Wong B, Huynh C, Tang B, et al
    Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:381-394.
    PubMed    
    Abstract available

  65. CACCIAPAGLIA F, Airo P, Fornaro M, Trerotoli P, et al
    Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients.
    Rheumatology (Oxford). 2023;62:1552-1558.
    PubMed    
    Abstract available

  66. GARCIA MVF, Souza R, Caruso P
    Predictors of invasive mechanical ventilation use in patients with acute decompensated pulmonary hypertension admitted to the intensive care unit.
    ERJ Open Res. 2023;9:00598-2022.
    PubMed    
    Abstract available

  67. HE M, Tao K, Xiang M, Sun J, et al
    Hpgd affects the progression of hypoxic pulmonary hypertension by regulating vascular remodeling.
    BMC Pulm Med. 2023;23:116.
    PubMed    
    Abstract available

  68. MA C, Xu Q, Huang S, Song J, et al
    The HIF-1alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
    FASEB J. 2023;37:e22906.
    PubMed    
    Abstract available

  69. ISHIDA K, Kohno H, Matsuura K, Sugiura T, et al
    Impact of residual pulmonary hypertension on long-term outcomes after pulmonary endarterectomy in the modern era.
    Pulm Circ. 2023;13:e12215.
    PubMed    
    Abstract available

  70. BOUSSEAU S, Sobrano Fais R, Gu S, Frump A, et al
    Pathophysiology and new advances in pulmonary hypertension.
    BMJ Med. 2023;2:e000137.
    PubMed    
    Abstract available

  71. PUGNALONI F, Capolupo I, Patel N, Giliberti P, et al
    Role of microRNAs in Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension.
    Int J Mol Sci. 2023;24:6656.
    PubMed    
    Abstract available

  72. MORIYAMA H, Endo J
    Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling.
    Int J Mol Sci. 2023;24:6619.
    PubMed    
    Abstract available

  73. CAMARA RP, Coelho FDN, Cruz-Martins N, Marques-Alves P, et al
    Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost-A Multicentre, Retrospective Study.
    Int J Mol Sci. 2023;24:6434.
    PubMed    
    Abstract available

  74. HE Z, Chang T, Chen Y, Wang H, et al
    PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis.
    Int J Mol Sci. 2023;24:6385.
    PubMed    
    Abstract available

  75. HOSOKAWA K, Abe K, Funakoshi K, Tamura Y, et al
    Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
    J Thromb Haemost. 2023 Apr 10:S1538-7836(23)00270.
    PubMed    
    Abstract available

  76. HUNGERFORD S, Kearney K, Song N, Kotlyar E, et al
    Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification.
    Physiol Rep. 2023;11:e15662.
    PubMed    
    Abstract available

  77. YURIDITSKY E, Horowitz JM, Lau JF
    Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism (PE) syndrome.
    Vasc Med. 2023 Apr 10:1358863X231165105. doi: 10.1177/1358863X231165105.
    PubMed    
    Abstract available

  78. SHINDO A, Ueda K, Minatsuki S, Nakayama Y, et al
    Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report.
    Front Genet. 2023;14:1148067.
    PubMed    
    Abstract available

  79. GONZALEZ-RIVAS D, Koziej PH, Sediqi S, Ruprecht B, et al
    Uniportal hybrid robotic-assisted right upper sleeve lobectomy in an 83-year-old patient with severe pulmonary hypertension.
    Ann Cardiothorac Surg. 2023;12:136-138.
    PubMed    


  80. SIAGIAN SN, Prakoso R, Mendel B, Hazami Z, et al
    Transesophageal echocardiography-guided percutaneous closure of multiple muscular ventricular septal defects with pulmonary hypertension using single device: A case report.
    Front Cardiovasc Med. 2023;10:1093563.
    PubMed    
    Abstract available

  81. ZHOU C, Tao J, Li S
    Case report: Unruptured sinus of Valsalva aneurysms causing postural angina pectoris and false "pulmonary hypertension".
    Front Cardiovasc Med. 2023;10:1120633.
    PubMed    
    Abstract available

  82. SANCHEZ-BECERRA JC, Guillen-Torres R, Becerra-Becerra R, Marquez-Gonzalez H, et al
    Targeted neonatal echocardiography and lung ultrasound in preterm infants with chronic lung disease with and without pulmonary hypertension, screened using a standardized algorithm.
    Front Pediatr. 2023;11:1104940.
    PubMed    
    Abstract available

  83. YU D, Zhang T, Zhou G, Wu Z, et al
    Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia.
    Respir Res. 2023;24:104.
    PubMed    
    Abstract available

  84. MARTINHO M, Cale R, Ferreira F, Alegria S, et al
    Chronic thromboembolic pulmonary hypertension - the challenging approach of a young patient with distal disease.
    Pulmonology. 2023 Apr 6:S2531-0437(23)00053-3. doi: 10.1016/j.pulmoe.2023.
    PubMed    


  85. WU PW, Yeh SJ, Lee PC, Pan KT, et al
    Hemodynamic and Echocardiographic Characteristics and the Presence of Pulmonary Hypertension in Patent Ductus Arteriosus Patients who Underwent Transcatheter Closure.
    Pediatr Cardiol. 2023 Apr 8. doi: 10.1007/s00246-023-03157.
    PubMed    
    Abstract available

  86. KORMAN BD, Lachant DJ, Castelino FV
    Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?
    Rheum Dis Clin North Am. 2023;49:345-357.
    PubMed    
    Abstract available

  87. VARJU C, Pauling JD, Saketkoo LA
    Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis.
    Rheum Dis Clin North Am. 2023;49:211-248.
    PubMed    
    Abstract available

  88. MARON BA
    Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer.
    J Am Heart Assoc. 2023 Apr 7:e029024. doi: 10.1161/JAHA.122.029024.
    PubMed    
    Abstract available

  89. MATSUO M, Doi T, Katsuki M, Yoshimura Y, et al
    Association between intraoperative pulmonary artery pressure and cardiovascular complications after off-pump coronary artery bypass surgery: a single-center observational study.
    BMC Anesthesiol. 2023;23:114.
    PubMed    
    Abstract available

  90. ZOLTY R
    Advances in the discovery of drugs that treat pulmonary arterial hypertension.
    Expert Opin Drug Discov. 2023;18:445-466.
    PubMed    
    Abstract available

  91. LIN KC, Yeh JN, Shao PL, Chiang JY, et al
    Jagged/Notch proteins promote endothelial-mesenchymal transition-mediated pulmonary arterial hypertension via upregulation of the expression of GATAs.
    J Cell Mol Med. 2023;27:1110-1130.
    PubMed    
    Abstract available

  92. YAMAGUCHI Y, Hosokawa S, Haraguchi G, Kajikawa Y, et al
    The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension.
    J Pharmacol Exp Ther. 2023;385:88-94.
    PubMed    
    Abstract available

  93. VISWANATHAN G, Rajagopal S
    De novo purine synthesis: a new target in pulmonary arterial hypertension?
    Eur Heart J. 2023 Feb 20:ehad078. doi: 10.1093.
    PubMed    


  94. OKOUR M, Thapar MM, Farrell C, Lukas MA, et al
    Pediatric Population Pharmacokinetic Modeling and Exposure-Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data.
    J Clin Pharmacol. 2023;63:593-603.
    PubMed    
    Abstract available

  95. ELMI-SARABI M, Couture E, Jarry S, Saade E, et al
    Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
    Can J Cardiol. 2023;39:474-482.
    PubMed    
    Abstract available

  96. CROWELL PR, Frederick MR, Fombin RA, Varghese NP, et al
    Prevalence of malnutrition in pediatric pulmonary hypertension cohort and role for registered dietitian involvement.
    Front Pediatr. 2023;11:995470.
    PubMed    
    Abstract available

  97. TSUBATA H, Nakanishi N, Itatani K, Takigami M, et al
    Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2023;13:6490.
    PubMed    
    Abstract available

  98. WEISS A, Yogeswaran A, Mamazhakypov A, Schermuly RT, et al
    Right ventricular failure in pulmonary hypertension: recent insights from experimental models.
    Herz. 2023 Apr 20. doi: 10.1007/s00059-023-05180.
    PubMed    
    Abstract available

  99. ZHENG W, Li T, Wei J, Yan Y, et al
    Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression.
    Korean J Physiol Pharmacol. 2023;27:209-220.
    PubMed    
    Abstract available

  100. JIN S, Zhao S, Wan X, Zhang M, et al
    A Positive Microbubble Study in Ventricular Septal Defect Patient Without Pulmonary Hypertension.
    JACC Case Rep. 2023;11:101782.
    PubMed    
    Abstract available

  101. CRNKOVIC S, Kwapiszewska G
    Guilt by Association - Stepwise Entanglement of the Role of HIF in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 Apr 19. doi: 10.1165/rcmb.2023-0103.
    PubMed    


  102. SHI Y, Liu J, Zhang R, Zhang M, et al
    Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
    Hypertension. 2023;80:1035-1047.
    PubMed    
    Abstract available

  103. GUO X, Li MX, Bayer C, Yang YQ, et al
    [Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism].
    Zhongguo Dang Dai Er Ke Za Zhi. 2023;25:407-414.
    PubMed    
    Abstract available

  104. WANG L, Wang F, Tuo Y, Wan H, et al
    Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.
    BMC Pulm Med. 2023;23:127.
    PubMed    
    Abstract available

  105. PALEVICIUTE E, Celutkiene J, Simbelyte T, Gumbiene L, et al
    Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial.
    Trials. 2023;24:281.
    PubMed    
    Abstract available

  106. YUAN R, Liu M, Cheng Y, Yan F, et al
    Biomimetic Nanoparticle-Mediated Target Delivery of Hypoxia-Responsive Plasmid of Angiotensin-Converting Enzyme 2 to Reverse Hypoxic Pulmonary Hypertension.
    ACS Nano. 2023 Apr 18. doi: 10.1021/acsnano.2c12190.
    PubMed    
    Abstract available

  107. ZHOU W, Du Z, Tao Y, Zhang GX, et al
    Effect of preoperative pulmonary artery pressure on the prognosis of end-stage heart failure patients after heart transplantation.
    J Cardiothorac Surg. 2023;18:154.
    PubMed    
    Abstract available

  108. HUANG W, Liu H, Pan Y, Wang X, et al
    A modified primary culture method of rat pulmonary vein smooth muscle cells.
    J Cardiothorac Surg. 2023;18:146.
    PubMed    
    Abstract available

  109. CARBONE RG, Monselise A, Barisione E, Fontana V, et al
    Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia.
    Intern Emerg Med. 2023 Apr 17. doi: 10.1007/s11739-023-03267.
    PubMed    
    Abstract available

  110. KAKALETSIS S, Malinowski M, Mathur M, Sugerman GP, et al
    Untangling the mechanisms of pulmonary hypertension-induced right ventricular stiffening in a large animal model.
    bioRxiv. 2023 Apr 6:2023.04.03.535491. doi: 10.1101/2023.04.03.535491.
    PubMed    
    Abstract available

  111. HINTON M, Thliveris JA, Hatch GM, Dakshinamurti S, et al
    Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle-Implications for hypoxic pulmonary hypertension.
    Front Physiol. 2023;14:1144574.
    PubMed    
    Abstract available

  112. GUO Y, He Z, Chen Z, Chen F, et al
    Inhibition of Th17 cells by donepezil ameliorates experimental lung fibrosis and pulmonary hypertension.
    Theranostics. 2023;13:1826-1842.
    PubMed    
    Abstract available

  113. YANG Y, Chen H, Dong Q, Liao K, et al
    Severity of functional tricuspid regurgitation is associated with mortality in patients with pulmonary hypertension in long-term follow-up.
    Pulm Circ. 2023;13:e12222.
    PubMed    
    Abstract available

  114. MADDIPATI V, Sankhyan P, Goswami DP, Mahajan A, et al
    Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.
    Pulm Circ. 2023;13:e12210.
    PubMed    
    Abstract available

  115. YUNG D, Jackson EO, Blumenfeld A, Redding G, et al
    A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension.
    Front Pediatr. 2023;11:1077422.
    PubMed    
    Abstract available

  116. MORALES-CANO D, Izquierdo-Garcia JL, Barreira B, Esquivel-Ruiz S, et al
    Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
    Front Pharmacol. 2023;14:1021535.
    PubMed    
    Abstract available

  117. YOSHITOMI Y, Suwa Y, Tsuchiya H, Goto M, et al
    Pulmonary Hypertension Associated with Anti-synthetase Syndrome: A Case Report and Literature Review.
    Intern Med. 2023 Apr 14. doi: 10.2169/internalmedicine.9809.
    PubMed    
    Abstract available

  118. DENG M, Liu A, Xu W, Yang H, et al
    Right and left ventricular blood pool T2 ratio on cardiac magnetic resonance imaging correlates with hemodynamics in patients with pulmonary hypertension.
    Insights Imaging. 2023;14:66.
    PubMed    
    Abstract available

  119. DE BIE FR, Avitabile CM, Flohr S, Land S, et al
    Treprostinil in neonates with congenital diaphragmatic hernia-related pulmonary hypertension.
    J Pediatr. 2023 Apr 12:113420. doi: 10.1016/j.jpeds.2023.113420.
    PubMed    
    Abstract available

  120. POPOVICH YM, Rosul MV, Sich PR, Laver OP, et al
    THROMBOLYSIS IN PULMONARY EMBOLISM TREATMENT.
    Wiad Lek. 2023;76:604-609.
    PubMed    
    Abstract available

  121. SHI J, Shao M, Zhou X, Lu Y, et al
    Postcardiac injury syndrome caused by radiofrequency catheter ablation of persistent atrial fibrillation: severe pulmonary arterial hypertension with severe tricuspid regurgitation: a rare case report and literature review.
    BMC Cardiovasc Disord. 2023;23:192.
    PubMed    
    Abstract available

  122. PLATT C, Longthorpe C, Sit J, Marks SD, et al
    Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series.
    Clin Exp Rheumatol. 2023 Apr 13. doi: 10.55563.
    PubMed    
    Abstract available

  123. BUENDIA JA, Patino DG, Lindarte EF
    Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis.
    Pediatr Pulmonol. 2023;58:1562-1568.
    PubMed    
    Abstract available

  124. HUANG Z, Dong F, Wang M, Hu F, et al
    Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis.
    Clin Exp Rheumatol. 2023;41:887-892.
    PubMed    
    Abstract available

  125. LI X, Zhang X, Hou X, Bing X, et al
    Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension.
    Apoptosis. 2023;28.
    PubMed    
    Abstract available

  126. TORTUM F, Tekin E, Gur A, Kerget B, et al
    Use of the PaO(2)/FiO(2) Ratio in Pulmonary Embolism: Evaluation of its Correlation with Pulmonary Arterial Computed Tomography Obstruction Index.
    Acad Radiol. 2023;30:893-899.
    PubMed    
    Abstract available

  127. OU Y, Zong D, Ouyang R
    Role of epigenetic abnormalities and intervention in obstructive sleep apnea target organs.
    Chin Med J (Engl). 2023;136:631-644.
    PubMed    
    Abstract available

  128. GILBERT RM, Gleghorn JP
    Connecting clinical, environmental, and genetic factors point to an essential role for vitamin A signaling in the pathogenesis of congenital diaphragmatic hernia.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L456-L467.
    PubMed    
    Abstract available

  129. BIGNARD J, Atassi F, Claude O, Ghigna MR, et al
    T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4(-/-))-deficient rats in basal and stress conditions.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L609-L624.
    PubMed    
    Abstract available

  130. MCNAMARA PJ, Lakshminrusimha S
    Maldevelopment of the Immature Pulmonary Vasculature and Prolonged Patency of the Ductus Arteriosus: Association or Cause?
    Am J Respir Crit Care Med. 2023;207:814-816.
    PubMed    


  131. ULRICH S
    A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance.
    Am J Respir Crit Care Med. 2023;207:972-974.
    PubMed    


  132. VANDERPOOL RR, Insel M, Kubba S, Rischard FP, et al
    The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.
    Am J Respir Crit Care Med. 2023;207:1100-1102.
    PubMed    


  133. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:1070-1079.
    PubMed    
    Abstract available

  134. CORNFIELD DN, Nogee LM
    Rare to "Ubiquitinous": Alveolar Capillary Dysplasia, FOXF1, and a Sly Approach to Angiogenesis.
    Am J Respir Crit Care Med. 2023;207:969-971.
    PubMed    


  135. PRADHAN A, Che L, Ustiyan V, Reza AA, et al
    Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;207:1042-1054.
    PubMed    
    Abstract available

  136. YANG J, Madani MM, Mahmud E, Kim NH, et al
    " Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension".
    Chest. 2023 Mar 27:S0012-3692(23)00457-9. doi: 10.1016/j.chest.2023.
    PubMed    
    Abstract available

  137. AL-QADI MO, Holbrook J, Ford HJ, Ceppe A, et al
    Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients with Precapillary Pulmonary Hypertension.
    Chest. 2023 Mar 27:S0012-3692(23)00458-0. doi: 10.1016/j.chest.2023.
    PubMed    
    Abstract available

  138. MORRIS TA, Fernandes TM, Channick R
    How we do it: evaluation of dyspnea and exercise intolerance after acute pulmonary embolism.
    Chest. 2022 Jul 2. pii: S0012-3692(22)01215-6. doi: 10.1016/j.chest.2022.
    PubMed    
    Abstract available

  139. FORBES LM, Bull TM, Lahm T, Make BJ, et al
    Exercise Testing in the Risk Assessment of Pulmonary Hypertension.
    Chest. 2023 Apr 13:S0012-3692(23)00509-3. doi: 10.1016/j.chest.2023.
    PubMed    


  140. WALTERS R, Vasilaki E, Aman J, Chen CN, et al
    SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
    Circulation. 2023 Apr 17. doi: 10.1161/CIRCULATIONAHA.122.061940.
    PubMed    
    Abstract available

  141. KAYAWAKE H, Date H
    Living-donor lobar lung transplantation: a viable option for recipients with pulmonary hypertension.
    Eur J Cardiothorac Surg. 2023 Apr 4:ezad132. doi: 10.1093.
    PubMed    


  142. ZENGIN A, Kalkan R, Yildiz Aydin K, Olgun Yildizeli S, et al
    Extracellular matrix collagen biomarker levels in patients who underwent pulmonary endarterectomy.
    Eur J Cardiothorac Surg. 2023;63:ezad106.
    PubMed    
    Abstract available

  143. KOUDSTAAL T, Boomars KA
    Inflammatory biomarkers in pulmonary arterial hypertension: ready for clinical implementation?
    Eur Respir J. 2023;61:2300018.
    PubMed    


  144. BOUCLY A, Tu L, Guignabert C, Rhodes C, et al
    Cytokines as prognostic biomarkers in pulmonary arterial hypertension.
    Eur Respir J. 2023;61:2201232.
    PubMed    
    Abstract available

  145. DE JONG CMM, Visser C, Bemelmans RHH, Boersma WG, et al
    Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
    Eur Respir J. 2023;61:2300171.
    PubMed    


  146. RATWATTE S, Playford D, Stewart S, Strange G, et al
    Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
    PubMed    
    Abstract available

  147. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
    PubMed    
    Abstract available

  148. LI SS, Liang S, Li L, Yang H, et al
    circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA.
    J Cardiovasc Pharmacol. 2023;81:292-299.
    PubMed    
    Abstract available

  149. STRUEBER M
    TREATMENT STRATEGIES FOR END-STAGE PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2023 Apr 4:S1053-2498(23)01814.
    PubMed    


  150. HOEPER MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al
    Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
    PubMed    
    Abstract available

  151. TAICHMAN DB, Leopold JA, Elliott G
    Continued Progress in Therapy for Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMe2300324.
    PubMed    


  152. TUKPAH AC, Rose JA, Seger DL, Dellaripa PF, et al
    Development and validation of algorithms to build an electronic health record based cohort of patients with systemic sclerosis.
    PLoS One. 2023;18:e0283775.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;